Enhanced Natural Killer Cell Immunotherapy by Rationally Assembling Fc Fragments of Antibodies onto Tumor Membranes

Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors

(2018) Linden C. Wyatt et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity

(2018) Lucas Ferrari de Andrade et al.   SCIENCE

Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade

(2018) Joy Hsu et al.   JOURNAL OF CLINICAL INVESTIGATION

Immunogenicity of protein aggregates of a monoclonal antibody generated by forced shaking stress with siliconized and nonsiliconized syringes in BALB/c mice

(2017) Tomonobu Uchino et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more

(2017) Laura Chiossone et al.   SEMINARS IN IMMUNOLOGY

Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody

(2016) Chao Wang et al.   ADVANCED MATERIALS

Tumor heterogeneity and circulating tumor cells

(2016) Chufeng Zhang et al.   CANCER LETTERS

Immunosurveillance and immunotherapy of tumors by innate immune cells

(2016) Alexandre Iannello et al.   CURRENT OPINION IN IMMUNOLOGY

Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches

(2016) Sebastian Carotta   Frontiers in Immunology

Optimization of anti-CD20 humanized antibody hu8E4 by site-directed mutation based on epitope analysis

(2015) Yalin Chen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy

(2015) J. J. Rojas et al.   CLINICAL CANCER RESEARCH

The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions

(2015) Thomas T. Tapmeier et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Enhancement of radiation effect on cancer cells by gold-pHLIP

(2015) Michael P. Antosh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer

(2015) Katayoun Rezvani et al.   Frontiers in Immunology

Cytokine therapy restores antitumor responses of NK cells rendered anergic in MHC I-deficient tumors

(2015) Michele Ardolino et al.   OncoImmunology

pHLIP-FIRE, a Cell Insertion-Triggered Fluorescent Probe for Imaging Tumors Demonstrates Targeted Cargo Delivery In Vivo

(2014) Alexander G. Karabadzhak et al.   ACS Chemical Biology

Cytokine therapy reverses NK cell anergy in MHC-deficient tumors

(2014) Michele Ardolino et al.   JOURNAL OF CLINICAL INVESTIGATION

Targeting Breast Tumors with pH (Low) Insertion Peptides

(2014) Ramona-Cosmina Adochite et al.   MOLECULAR PHARMACEUTICS

MicroRNA silencing for cancer therapy targeted to the tumour microenvironment

(2014) Christopher J. Cheng et al.   NATURE

A Controlled-Release Nanocarrier with Extracellular pH Value Driven Tumor Targeting and Translocation for Drug Delivery

(2013) Zilong Zhao et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Cancer heterogeneity: implications for targeted therapeutics

(2013) R Fisher et al.   BRITISH JOURNAL OF CANCER

Design and development of therapies using chimeric antigen receptor-expressing T cells

(2013) Gianpietro Dotti et al.   IMMUNOLOGICAL REVIEWS

CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma

(2013) J Chu et al.   LEUKEMIA

Tumor Fibroblast Specific Activation of a Hybrid Ferritin Nanocage-Based Optical Probe for Tumor Microenvironment Imaging

(2013) Tianjiao Ji et al.   Small

Hybrid Ferritin Nanoparticles as Activatable Probes for Tumor Imaging

(2011) Xin Lin et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Advances in the assessment and control of the effector functions of therapeutic antibodies

(2011) Xu-Rong Jiang et al.   NATURE REVIEWS DRUG DISCOVERY

Tumor Antigen–Targeted, Monoclonal Antibody–Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape

(2010) Robert L. Ferris et al.   JOURNAL OF CLINICAL ONCOLOGY

New drugs for aggressive B-cell and T-cell lymphomas

(2010) Niels Murawski et al.   LANCET ONCOLOGY

pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path

(2010) O. A. Andreev et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation

(2010) M. An et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Novel Technology for the Imaging of Acidic Prostate Tumors by Positron Emission Tomography

(2009) A. L. Vavere et al.   CANCER RESEARCH

A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment

(2009) S. E. Taube et al.   JNCI-Journal of the National Cancer Institute

Functions of natural killer cells

(2008) Eric Vivier et al.   NATURE IMMUNOLOGY

Self-tolerance of Human Natural Killer Cells Lacking Self-HLA-specific Inhibitory Receptors

(2008) J. Hasenkamp et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Association of CD47 with Natural Killer Cell-Mediated Cytotoxicity of Head-and-Neck Squamous Cell Carcinoma Lines

(2008) Min Jung Kim et al.   TUMOR BIOLOGY